Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)

Chan, Bryan K.; Seward, Eileen; Lainchbury, Michael; Brewer, Thomas F.; An, Le; Blench, Toby; Cartwright, Matthew W.; Chan, Grace Ka Yan; Choo, Edna F.; Drummond, Jason; Elliott, Richard L.; Gancia, Emanuela; Gazzard, Lewis; Hu, Baihua; Jones, Graham E.; Luo, Xifeng; Madin, Andrew; Malhotra, Sushant; Moffat, John G.; Pang, Jodie; Salphati, Laurent; Sneeringer, Christopher J.; Stivala, Craig E.; Wei, Binqing; Wang, Weiru; Wu, Ping; Heffron, Timothy P.

doi:10.1021/acsmedchemlett.1c00473

Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)

Journal Article · Fri Dec 31 23:00:00 EST 2021 · ACS Med. Chem. Lett.

DOI:https://doi.org/10.1021/acsmedchemlett.1c00473· OSTI ID:1844738

Chan, Bryan K.; Seward, Eileen; Lainchbury, Michael; Brewer, Thomas F.; An, Le; Blench, Toby; Cartwright, Matthew W.; Chan, Grace Ka Yan; Choo, Edna F.; Drummond, Jason; Elliott, Richard L.; Gancia, Emanuela; Gazzard, Lewis; Hu, Baihua; Jones, Graham E.; Luo, Xifeng; Madin, Andrew; Malhotra, Sushant; Moffat, John G.; Pang, Jodie more »

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1844738

Journal Information:: ACS Med. Chem. Lett., Journal Name: ACS Med. Chem. Lett. Journal Issue: (1) Vol. 13

Country of Publication:: United States

Language:: ENGLISH

References (22)

The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function Hernandez, Sairy; Qing, Jing; Thibodeau, Rebecca Hong Cell Reports, Vol. 25, Issue 1 https://doi.org/10.1016/j.celrep.2018.09.012	journal	October 2018
Structural Basis for Targeting the Folded P-Loop Conformation of c-MET Collie, Gavin W.; Michaelides, Iacovos N.; Embrey, Kevin ACS Medicinal Chemistry Letters, Vol. 12, Issue 1 https://doi.org/10.1021/acsmedchemlett.0c00392	journal	December 2020
Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer Wu, Ping; Sneeringer, Christopher J.; Pitts, Keith E. Structure, Vol. 27, Issue 1 https://doi.org/10.1016/j.str.2018.10.025	journal	January 2019
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential Sharma, Padmanee; Allison, James P. Cell, Vol. 161, Issue 2 https://doi.org/10.1016/j.cell.2015.03.030	journal	April 2015
Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1 Degnan, Andrew P.; Kumi, Godwin K.; Allard, Christopher W. ACS Medicinal Chemistry Letters, Vol. 12, Issue 3 https://doi.org/10.1021/acsmedchemlett.0c00660	journal	February 2021
The Capable ABL: What Is Its Biological Function? Wang, Jean Y. J. Molecular and Cellular Biology, Vol. 34, Issue 7 https://doi.org/10.1128/MCB.01454-13	journal	April 2014
The role of ligand efficiency metrics in drug discovery Hopkins, Andrew L.; Keserü, György M.; Leeson, Paul D. Nature Reviews Drug Discovery, Vol. 13, Issue 2 https://doi.org/10.1038/nrd4163	journal	January 2014
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor You, Dan; Hillerman, Stephen; Locke, Gregory Journal for ImmunoTherapy of Cancer, Vol. 9, Issue 1 https://doi.org/10.1136/jitc-2020-001402	journal	January 2021
HPK1 as a novel target for cancer immunotherapy Sawasdikosol, Sansana; Zha, Renyuan; Yang, Boyu Immunologic Research, Vol. 54, Issue 1-3 https://doi.org/10.1007/s12026-012-8319-1	journal	April 2012
Structure, Regulation, Signaling, and Targeting of Abl Kinases in Cancer Hantschel, O. Genes & Cancer, Vol. 3, Issue 5-6 https://doi.org/10.1177/1947601912458584	journal	May 2012
Inhibitors of immuno-oncology target HPK1 – a patent review (2016 to 2020) Linney, Ian D.; Kaila, Neelu Expert Opinion on Therapeutic Patents, Vol. 31, Issue 10 https://doi.org/10.1080/13543776.2021.1924671	journal	May 2021
Understanding the Impact of the P-loop Conformation on Kinase Selectivity Guimarães, Cristiano R. W.; Rai, Brajesh K.; Munchhof, Michael J. Journal of Chemical Information and Modeling, Vol. 51, Issue 6 https://doi.org/10.1021/ci200153c	journal	May 2011
Identification of Potent Reverse Indazole Inhibitors for HPK1 Yu, Elsie C.; Methot, Joey L.; Fradera, Xavier ACS Medicinal Chemistry Letters, Vol. 12, Issue 3 https://doi.org/10.1021/acsmedchemlett.0c00672	journal	March 2021
Oncology Meets Immunology: The Cancer-Immunity Cycle Chen, Daniel S.; Mellman, Ira Immunity, Vol. 39, Issue 1 https://doi.org/10.1016/j.immuni.2013.07.012	journal	July 2013
Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation Palacios, Emil H.; Weiss, Arthur Oncogene, Vol. 23, Issue 48 https://doi.org/10.1038/sj.onc.1208074	journal	October 2004
Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD2 receptors CRTH2 and DP Johnson, Michael G.; Liu, Jim (Jiwen); Li, An-Rong Bioorganic & Medicinal Chemistry Letters, Vol. 24, Issue 13 https://doi.org/10.1016/j.bmcl.2014.04.092	journal	July 2014
The influence of drug-like concepts on decision-making in medicinal chemistry Leeson, Paul D.; Springthorpe, Brian Nature Reviews Drug Discovery, Vol. 6, Issue 11 https://doi.org/10.1038/nrd2445	journal	November 2007
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds Vara, Brandon A.; Levi, Samuel M.; Achab, Abdelghani ACS Medicinal Chemistry Letters, Vol. 12, Issue 4 https://doi.org/10.1021/acsmedchemlett.1c00096	journal	March 2021
Combination cancer immunotherapy and new immunomodulatory targets Mahoney, Kathleen M.; Rennert, Paul D.; Freeman, Gordon J. Nature Reviews Drug Discovery, Vol. 14, Issue 8 https://doi.org/10.1038/nrd4591	journal	July 2015
A perspective on HPK1 as a novel immuno-oncology drug target Sawasdikosol, Sansana; Burakoff, Steven eLife, Vol. 9 https://doi.org/10.7554/eLife.55122	journal	September 2020
Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A. Bioorganic & Medicinal Chemistry Letters, Vol. 19, Issue 15 https://doi.org/10.1016/j.bmcl.2009.05.062	journal	August 2009
Current Status and Future Directions of the Immune Checkpoint Inhibitors Ipilimumab, Pembrolizumab, and Nivolumab in Oncology Barbee, Meagan S.; Ogunniyi, Adebayo; Horvat, Troy Z. Annals of Pharmacotherapy, Vol. 49, Issue 8 https://doi.org/10.1177/1060028015586218	journal	May 2015

Similar Records

Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer

Journal Article · Mon Dec 31 23:00:00 EST 2018 · Structure · OSTI ID:1499766

Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer

Journal Article · Mon Dec 31 23:00:00 EST 2018 · Structure · OSTI ID:1580761

Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (De

Journal Article · Mon Jun 01 00:00:00 EDT 2020 · J. Med. Chem. · OSTI ID:1833688

Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)

Citation Formats

References (22)

Similar Records

Related Subjects